HUGE (fsdpharma.com) יחס שווי שוק לשווי בספרים

The success of FSD Pharma Inc. (HUGE) is based on clinical test results and patent protection in neurobiology. The deviation of market valuation from book value confirms this dependency, where the value of 0.30 determines the magnitude of the metric. High margin potential is secured by intellectual property, however, a revenue deficit and R&D expenses are leading to a gradual depletion of the company's cash reserves.

This indicator reflects the ratio of the business's market value to the book value of its net assets. By analyzing the ratio of market capitalization to book capital, an investor assesses the market premium over tangible assets. The metric is calculated by dividing current capitalization by total equity, demonstrating the degree of stock overvaluation. For FSD Pharma Inc. (HUGE), this gap is driven by profit expectations amid risks of supply chain disruptions. High values warn of a potential correction should the geopolitical situation deteriorate.